Skip to main navigation Skip to search Skip to main content

A large-scale seroprevalence of Epstein-Barr virus in taiwan

  • Chao Yu Chen
  • , Kuan Ying A. Huang
  • , Jen Hsiang Shen
  • , Kuo Chien Tsao
  • , Yhu Chering Huang
  • Chang Gung University
  • Chang Gung Memorial Hospital

Research output: Contribution to journalJournal Article peer-review

63 Scopus citations

Abstract

Background Epstein-Barr virus (EBV) causes a variety of clinical manifestations from asymptomatic infection to acute infectious mononucleosis in human. Moreover, the EBV infection is associated with malignancies. The large-scale EBV seroepidemiology across all age groups has been lacking in Taiwan. Methods A total of 1411 serum samples were tested to examine the seroprevalence of EBV in 2007. The samples were collected during an island-wide seroepidemiological survey of vaccine preventable diseases in Taiwan. The enzyme-linked immunosorbent assay was performed to detect anti-EBV viral capsid IgG in sera. Demographic and personal health data were obtained by questionnaires. Results The overall weighted seropositive rate of EBV was 88.5% (95% CI, 86.7%- 90.1%). The seropositive rate of EBV reached 52.8% (95% CI, 44.0%-61.6%) in children aged 2 years, rapidly rose to 88.7%(95% CI, 79.0%-95.1%) in those aged 5-7 years and 93.0%(95%CI, 83.0%-98.1%) for those aged 14-16 years. Age and higher educational level were associated with the increased EBV seropositive rate. Conclusion In Taiwan, people had the EBV infection early in life. Children under 7 years should be the primary target popution of public health measures in the future.

Original languageEnglish
Article numbere0115836
JournalPLoS ONE
Volume10
Issue number1
DOIs
StatePublished - 23 01 2015
Externally publishedYes

Bibliographical note

Publisher Copyright:
© 2015 Chen et al.

Fingerprint

Dive into the research topics of 'A large-scale seroprevalence of Epstein-Barr virus in taiwan'. Together they form a unique fingerprint.

Cite this